Infectious Vaccines Market Analysis: Global Industry Size, Growth and Forecast

Report ID : 1330105 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Infectious Vaccines Market is categorized based on Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, mRNA Vaccines) and Disease Target (Viral Infections, Bacterial Infections, Parasitic Infections, Fungal Infections, Vector-borne Diseases) and Administration Route (Intramuscular, Subcutaneous, Intranasal, Oral, Transdermal) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

Valued at 50 billion USD in 2023, the Infectious Vaccines Market size is expected to grow to 100 billion USD by 2033, with a CAGR of 7.5% from 2024 to 2033. The report comprises various segments and analyzes the trends and factors playing a substantial role in the market.

Infectious vaccines play an important role on a global scale and have a market size that is anticipated to grow in response to a growing need for prevention suggesting a shifting focus towards health promotion. The rationale for this is summed up by the increase public literacy about vaccination and the continual progress in vaccine development. The demand for such vaccines which have the capability of preventing bacterial/viral infections and curtailing epidemic spread and boosting population’s immunity is continuously on the rise. 

As the situation stands now, the emerging and existing trends in the infectious vaccines space with the COVID-19 pandemic has highlighted how crucial the role of vaccine development is towards greater public health outcomes. Vaccine delivery mechanisms have been prioritized by pharmaceutical companies, businesses, and other organizations as a result of the unprecedented global health crisis that impacted everyone and everything. It will be very interesting to see how quickly the market advances, which appears to be going in that direction with developments such as mRNA vaccines and other advanced distribution tools that will help improve their effectiveness while also making them readily available.

The infectious vaccines market offers many opportunities for investors and relevant players in the healthcare industry due to the strong pipeline of vaccine candidates and the increasing number of regulatory approvals. Attempts have to be made to analyse market developments, regulations and competitive dynamics for stakeholders in this industry. At Verified Industry Insights, we examine various aspects of the infectious vaccines market as it affects businesses and helps them strategize to take advantage of new opportunities.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	Pfizer, Moderna, Merck & Co., GlaxoSmithKline, Sanofi, Johnson & Johnson, AstraZeneca, Novavax, Bharat Biotech, Sinovac Biotech, GSK Biologicals
SEGMENTS COVERED	By Vaccine Type - Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, mRNA Vaccines By Disease Target - Viral Infections, Bacterial Infections, Parasitic Infections, Fungal Infections, Vector-borne Diseases By Administration Route - Intramuscular, Subcutaneous, Intranasal, Oral, Transdermal By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Infectious Vaccines Market Dynamics

The Infectious Vaccines Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Infectious Vaccines Market

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• Pfizer
• Moderna
• Merck & Co.
• GlaxoSmithKline
• Sanofi
• Johnson & Johnson
• AstraZeneca
• Novavax
• Bharat Biotech
• Sinovac Biotech
• GSK Biologicals

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved